Drug Research
Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal health and ecosystems
The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally.
The Food and Agriculture...
News
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Health Canada has granted expanded authorization...
Drug Research
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. announced a collaboration and licensing agreement to create conditionally-activated investigational bispecific cancer therapies utilizing CytomX's Probody® therapeutic...
News
UPS Completes Acquisition of Bomi Group Multi-National Healthcare Logistics Firm
UPS announced that it has closed on the acquisition of Bomi Group, an industry-leading multi-national healthcare logistics provider. Through the acquisition, the company's healthcare...
News
How Product Inspection Affects The Quality of Liquid Drugs
More than 143 million COVID-19 doses had been given in the UK as of the end of May 2022 since the start of this...
Articles
Overcoming 5 of the most prominent challenges in lentiviral vector development and manufacturing
Viral vectors play a vital role in the development of cell and gene therapies (C>s). By delivering genetic material to patients’ cells to replace...
Articles
Room for All: Opportunities for Gender Diversity Within the Health Tech Industry
The healthcare industry has undergone evident transformations in the past ten years. Innovations involving artificial intelligence (AI) driven technologies have uplifted diagnostics and aftercare,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read














